Meeder Asset Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Meeder Asset Management’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-568	Closed	-$1K	–	2591
2020 Q1	$1K	Sell	568 -3,893	-87%	-$10.3K	﹤0.01%	2260
2019 Q4	$8K	Sell	4,461 -291	-6%	-$485	﹤0.01%	1655
2019 Q3	$7K	Buy	4,752 +3,481	+274%	+$7.6K	﹤0.01%	1670
2019 Q2	$4K	Sell	1,271 -5,472	-81%	-$21.8K	﹤0.01%	1758
2019 Q1	$33K	Sell	6,743 -113	-2%	-$556	﹤0.01%	960
2018 Q4	$30K	Buy	+6,856	New	+$52.9K	﹤0.01%	947

Other funds holding SURF

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meeder Asset Management's SURF Position: Q2 2020 in Review

Meeder Asset Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2020, closing a stake of 568 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in SURF in Q4 2018 and held it in 6 quarters. The position peaked at $33K in Q1 2019. 44 funds tracked by Wall St. Rank hold SURF as of Q2 2020.

Meeder Asset Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Meeder Asset Management sold 568 Surface Oncology, Inc. Common Stock shares in Q2 2020, an estimated $1K.
Meeder Asset Management first reported a position in Surface Oncology, Inc. Common Stock in Q4 2018 and held it in 6 quarters.
Meeder Asset Management's Surface Oncology, Inc. Common Stock position peaked at $33K in Q1 2019.
44 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.